Filter
41
Text search:
Global
Initiative
for
Chronic
Obstructive
Lung
Disease
(GOLD)
Featured
Recommendations
3
New Publications
8
Language
Document type
Studies & Reports
15
No document type
13
Guidelines
8
Strategic & Response Plan
3
Videos
1
Fact sheets
1
Countries / Regions
Global
17
South Africa
3
Nigeria
2
Africa
2
Guinea-Bissau
1
Ethiopia
1
Uganda
1
Philippines
1
India
1
Kenya
1
Tanzania
1
Mozambique
1
Argentina
1
Angola
1
Paraguay
1
Authors & Publishers
Publication Years
Category
Public Health
18
Countries
15
Capacity Building
1
Toolboxes
NCDs
22
TB
2
Global Health Education
2
COVID-19
2
Polio
1
HIV
1
Planetary Health
1
Health Financing Toolbox
1
The aim of the GOLD Report is to provide a non-biased review of the current evidence for the assessment, diagnosis and treatment of people with COPD. One of the strengths of
...
These podcasts are produced for educational discussions only. Reference to any specific product, treatment, or entity does not constitute an endorsement. The views expressed by speakers are their own and do not necessarily reflect the view of
...
Chronic Obstructive Pulmonary Disease (COPD) is now one of the top three causes of death worldwide and 90% of these deaths occur in low- and middle
...
The GOLD website is dedicated to providing comprehensive information on Chronic Obstructive Pulmonary D
...
The GOLD 2023 report provides a comprehensive update on the global strategy for diagnosing, managing, and preventing
...
The "GOLD Patient Guide 2019" explains Chronic Obstructive Pulmonary Disease (COPD), its causes,
...
Chronic obstructive pulmonary disease (COPD) is a complex disease that requires differential dia
...
Long Acting Muscarinic Antagonists (LAMA) such as tiotropium and glycopyrronium are used in the management of COPD1. They have been shown to improve lung function, quality of life and exercise tolerance. They have also been associated with reduced C
...
Chronic respiratory diseases, such as asthma and
chronic obstructive pulmonary disease, kill mo
...
The article "Under- and over-diagnosis of COPD: a global perspective" reviews the worldwide variation in the prevalence of chronic obstructive pulm
...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international
...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeon
...
Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a
...
There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the Af
...
The document "Appropriate use and withdrawal of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD)" from t
...
Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still impos
...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge an
...
The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education,
...
Joining efforts to control two trelated global epidemics.
A Guidebook for Medical and Professional Schools, Second Edition.
This book represents a significant step to engage health professions schools in addressing global health challenges
